Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
Basic & Clinical Pharmacology & Toxicology
|
July 13, 2018
Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target
Teemu A Natunen, Mikko Gynther, Hannah Rostalski, et al.
Neurochemical Research
|
December 10, 2014
Blood-brain barrier permeability and brain uptake mechanism of kainic acid and dihydrokainic acid
Mikko Gynther, Aleksanteri Petsalo, Steen H Hansen, et al.
Journal of Pharmaceutical Sciences
|
May 23, 2023
Monoacylglycerol Lipase Inhibitor JJKK048 Ameliorates ABCG2 Transporter-Mediated Regorafenib Resistance Induced by Hypoxia in Triple Negative Breast Cancer Cells
Elena Puris, Sabrina Petralla, Seppo Auriola, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 14, 2023
In vitro identification of decreased function phenotype ABCG2 variants
Laura Suominen, Noora Sjöstedt, Kati-Sisko Vellonen, et al.
Frontiers in Pharmacology
|
April 4, 2024
Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease
Elena Puris, Liudmila Saveleva, Seppo Auriola, et al.
Molecular Pharmaceutics
|
June 9, 2016
Systemic and Brain Pharmacokinetics of Perforin Inhibitor Prodrugs
Mikko Gynther, Darryl S Pickering, Julie A Spicer, et al.
Molecular Pharmaceutics
|
July 21, 2011
Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery
Lauri Peura, Kalle Malmioja, Krista Laine, et al.
International Journal of Pharmaceutics
|
December 26, 2015
L-Type amino acid transporter 1 (lat1)-mediated targeted delivery of perforin inhibitors
Kristiina M Huttunen, Johanna Huttunen, Imke Aufderhaar, et al.
Journal of Medicinal Chemistry
|
June 3, 2016
A Selective and Slowly Reversible Inhibitor of l-Type Amino Acid Transporter 1 (LAT1) Potentiates Antiproliferative Drug Efficacy in Cancer Cells
Kristiina M Huttunen, Mikko Gynther, Johanna Huttunen, et al.
Journal of Medicinal Chemistry
|
May 1, 2009
Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats
Mikko Gynther, Jarmo Ropponen, Krista Laine, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
Basic & Clinical Pharmacology & Toxicology
|
July 13, 2018
Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target
Teemu A Natunen, Mikko Gynther, Hannah Rostalski, et al.
Neurochemical Research
|
December 10, 2014
Blood-brain barrier permeability and brain uptake mechanism of kainic acid and dihydrokainic acid
Mikko Gynther, Aleksanteri Petsalo, Steen H Hansen, et al.
Journal of Pharmaceutical Sciences
|
May 23, 2023
Monoacylglycerol Lipase Inhibitor JJKK048 Ameliorates ABCG2 Transporter-Mediated Regorafenib Resistance Induced by Hypoxia in Triple Negative Breast Cancer Cells
Elena Puris, Sabrina Petralla, Seppo Auriola, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
July 14, 2023
In vitro identification of decreased function phenotype ABCG2 variants
Laura Suominen, Noora Sjöstedt, Kati-Sisko Vellonen, et al.
Frontiers in Pharmacology
|
April 4, 2024
Sex-specific changes in protein expression of membrane transporters in the brain cortex of 5xFAD mouse model of Alzheimer's disease
Elena Puris, Liudmila Saveleva, Seppo Auriola, et al.
Molecular Pharmaceutics
|
June 9, 2016
Systemic and Brain Pharmacokinetics of Perforin Inhibitor Prodrugs
Mikko Gynther, Darryl S Pickering, Julie A Spicer, et al.
Molecular Pharmaceutics
|
July 21, 2011
Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery
Lauri Peura, Kalle Malmioja, Krista Laine, et al.
International Journal of Pharmaceutics
|
December 26, 2015
L-Type amino acid transporter 1 (lat1)-mediated targeted delivery of perforin inhibitors
Kristiina M Huttunen, Johanna Huttunen, Imke Aufderhaar, et al.
Journal of Medicinal Chemistry
|
June 3, 2016
A Selective and Slowly Reversible Inhibitor of l-Type Amino Acid Transporter 1 (LAT1) Potentiates Antiproliferative Drug Efficacy in Cancer Cells
Kristiina M Huttunen, Mikko Gynther, Johanna Huttunen, et al.
Journal of Medicinal Chemistry
|
May 1, 2009
Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats
Mikko Gynther, Jarmo Ropponen, Krista Laine, et al.
Page
of 6